Arthur L Weaver

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. doi request reprint Current and emerging treatments for mild/moderate acute ambulatory pain
    Arthur L Weaver
    Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA
    Am J Ther 15:S12-6. 2008
  2. ncbi request reprint Epidemiology of gout
    Arthur L Weaver
    Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, USA
    Cleve Clin J Med 75:S9-12. 2008
  3. ncbi request reprint Case 3: acute gout-risk factors and inappropriate therapy
    Arthur L Weaver
    Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Med 119:S9-12. 2006
  4. ncbi request reprint Case 1: differential diagnosis of an acute gouty attack
    Arthur L Weaver
    Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Med 119:S2-3. 2006
  5. ncbi request reprint Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
    Arthur L Weaver
    University of Nebraska Medical Center, Omaha, NE, USA
    Curr Med Res Opin 22:185-98. 2006
  6. ncbi request reprint Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone
    Arthur L Weaver
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Clin Rheumatol 12:17-25. 2006
  7. doi request reprint Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989
    Grant W Cannon
    Division of Rheumatology, University of Utah, Salt Lake City, UT 84132, USA
    Arthritis Rheum 58:S79-88. 2008
  8. ncbi request reprint Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:1205-15. 2005
  9. ncbi request reprint Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R Mikuls
    Section of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha Veterans Administration Medical Center, 983025 Nebraska Medical Center, Omaha, NE 68198, USA
    Curr Rheumatol Rep 5:270-7. 2003
  10. pmc Current state of therapy for pain and inflammation
    Steven B Abramson
    New York University School of Medicine, New York, USA
    Arthritis Res Ther 7:S1-6. 2005

Detail Information

Publications16

  1. doi request reprint Current and emerging treatments for mild/moderate acute ambulatory pain
    Arthur L Weaver
    Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA
    Am J Ther 15:S12-6. 2008
    ..Topical NSAIDs and other formulations that may prove to be safer than currently available agents also are addressed...
  2. ncbi request reprint Epidemiology of gout
    Arthur L Weaver
    Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, USA
    Cleve Clin J Med 75:S9-12. 2008
    ..While dietary and lifestyle modification may be useful as adjunctive measures, such changes do not replace pharmacologic treatments for gout or associated comorbidities...
  3. ncbi request reprint Case 3: acute gout-risk factors and inappropriate therapy
    Arthur L Weaver
    Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Med 119:S9-12. 2006
  4. ncbi request reprint Case 1: differential diagnosis of an acute gouty attack
    Arthur L Weaver
    Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Med 119:S2-3. 2006
  5. ncbi request reprint Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
    Arthur L Weaver
    University of Nebraska Medical Center, Omaha, NE, USA
    Curr Med Res Opin 22:185-98. 2006
    ..To evaluate the effectiveness of select biologics, methotrexate (MTX), and other disease-modifying anti-rheumatic drugs (DMARDs) in the management of adult rheumatoid arthritis (RA) in routine clinical practice...
  6. ncbi request reprint Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone
    Arthur L Weaver
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Clin Rheumatol 12:17-25. 2006
    ..Rofecoxib and nabumetone were developed to provide gastrointestinal benefits over traditional nonsteroidal antiinflammatory drugs (NSAIDs). However, there is limited comparative information relating to these 2 drugs...
  7. doi request reprint Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989
    Grant W Cannon
    Division of Rheumatology, University of Utah, Salt Lake City, UT 84132, USA
    Arthritis Rheum 58:S79-88. 2008
    ..Some clinical improvement occurred in both groups of patients. Although the improvement with rHu gamma-IFN was greater than that with placebo, the differences were generally not statistically significant...
  8. ncbi request reprint Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:1205-15. 2005
    ..To assess the efficacy, safety, and tolerability of etoricoxib, a cyclooxygenase 2 (COX-2) selective inhibitor, administered continuously over 52 weeks for the treatment of ankylosing spondylitis (AS)...
  9. ncbi request reprint Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R Mikuls
    Section of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha Veterans Administration Medical Center, 983025 Nebraska Medical Center, Omaha, NE 68198, USA
    Curr Rheumatol Rep 5:270-7. 2003
    ..This review evaluates the unique attributes of the available TNFa inhibitors, focusing specifically on recent reports providing important insight into the understanding of drug-related efficacy and toxicity...
  10. pmc Current state of therapy for pain and inflammation
    Steven B Abramson
    New York University School of Medicine, New York, USA
    Arthritis Res Ther 7:S1-6. 2005
    ....
  11. ncbi request reprint A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis
    John D Bradley
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Rheumatol 32:417-23. 2005
    ..To evaluate the efficacy and safety of a selective inhibitor of secretory phospholipase (sPLA2), LY333013, in the treatment of rheumatoid arthritis (RA)...
  12. ncbi request reprint Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials
    Wendy P Battisti
    Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    J Pain 5:511-20. 2004
    ..5 mg (P = .01) compared with nabumetone. Rofecoxib treatment, with its faster onset of OA efficacy and lower rates of related discontinuations, might provide efficacy advantages in the treatment of OA pain...
  13. ncbi request reprint Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results
    Roy M Fleischmann
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    J Rheumatol 30:691-6. 2003
    ..We compared the safety and efficacy of etanercept (Enbrel) in patients with RA who were > or = 65 years to those < 65 years in open-label and double-blind, randomized clinical trials...
  14. ncbi request reprint Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs
    Arthur L Weaver
    Arch Intern Med 162:2248-9. 2002
  15. ncbi request reprint Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes
    Mark C Genovese
    Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road 203, Palo Alto, CA 94304, USA
    Arthritis Rheum 46:1443-50. 2002
    ..To compare the clinical and radiographic outcomes in patients with rheumatoid arthritis (RA) who received monotherapy with either etanercept or methotrexate (MTX) for 2 years and to assess the safety of this therapy...
  16. ncbi request reprint Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial
    Gregory P Geba
    Merck and Co Inc, US Human Health, PO Box 4, West Point, PA 19486 0004, USA
    JAMA 287:64-71. 2002
    ..Osteoarthritis (OA) is often treated with nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, or specific inhibitors of cyclooxygenase 2 (COX-2)...